Literature DB >> 10026188

Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion.

K D Chavin1, S Yang, H Z Lin, J Chatham, V P Chacko, J B Hoek, E Walajtys-Rode, A Rashid, C H Chen, C C Huang, T C Wu, M D Lane, A M Diehl.   

Abstract

Uncoupling protein 2 (UCP2) uncouples respiration from oxidative phosphorylation and may contribute to obesity through effects on energy metabolism. Because basal metabolic rate is decreased in obesity, UCP2 expression is predicted to be reduced. Paradoxically, hepatic expression of UCP2 mRNA is increased in genetically obese (ob/ob) mice. In situ hybridization and immunohistochemical analysis of ob/ob livers demonstrate that UCP2 mRNA and protein expression are increased in hepatocytes, which do not express UCP2 in lean mice. Mitochondria isolated from ob/ob livers exhibit an increased rate of H+ leak which partially dissipates the mitochondrial membrane potential when the rate of electron transport is suppressed. In addition, hepatic ATP stores are reduced and these livers are more vulnerable to necrosis after transient hepatic ischemia. Hence, hepatocytes adapt to obesity by up-regulating UCP2. However, because this decreases the efficiency of energy trapping, the cells become vulnerable to ATP depletion when energy needs increase acutely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026188     DOI: 10.1074/jbc.274.9.5692

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  105 in total

Review 1.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

Authors:  Jiansheng Huang; Yuzhi Jia; Tao Fu; Navin Viswakarma; Liang Bai; M Sambasiva Rao; Yijun Zhu; Jayme Borensztajn; Janardan K Reddy
Journal:  FASEB J       Date:  2011-10-18       Impact factor: 5.191

Review 3.  Uncoupling proteins: role in insulin resistance and insulin insufficiency.

Authors:  Catherine B Chan; Mary-Ellen Harper
Journal:  Curr Diabetes Rev       Date:  2006-08

Review 4.  Hepatic steatosis and type 2 diabetes mellitus.

Authors:  Jeanne M Clark; Anna Mae Diehl
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

5.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity.

Authors:  E Madison Sullivan; Amy Fix; Miranda J Crouch; Genevieve C Sparagna; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh
Journal:  J Nutr Biochem       Date:  2017-04-12       Impact factor: 6.048

7.  Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion.

Authors:  Z P Evans; B S Mandavilli; J D Ellett; D Rodwell; M W Fariss; R N Fiorini; R G Schnellmann; M G Schmidt; K Chavin
Journal:  Transplant Proc       Date:  2009-12       Impact factor: 1.066

8.  Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver.

Authors:  Chi-Dan Wan; Chun-You Wang; Tao Liu; Rui Cheng; Hong-Bo Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

Review 9.  Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

Authors:  György Baffy
Journal:  J Hepatol       Date:  2009-03-31       Impact factor: 25.083

10.  The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.

Authors:  Peng Chen; Chunying Li; Wenqaing Pang; Yue Zhao; Wei Dong; Shiming Wang; Jianfa Zhang
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.